112 related articles for article (PubMed ID: 3008768)
1. Selective inhibition of replication of the AIDS-associated virus HTLV-III/LAV by synthetic D-penicillamine.
Chandra P; Sarin PS
Arzneimittelforschung; 1986 Feb; 36(2):184-6. PubMed ID: 3008768
[TBL] [Abstract][Full Text] [Related]
2. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
[TBL] [Abstract][Full Text] [Related]
3. Effect of D-penicillamine on the expression and propagation of the human immunodeficiency virus by H9 T-lymphoblastoid cells.
Bitterlich G; Larcher C; Sölder B; Hengster P; Myones BL; Hofbauer J; Schulz TF; Wachter H; Dierich MP
Arzneimittelforschung; 1989 Aug; 39(8):825-8. PubMed ID: 2818669
[TBL] [Abstract][Full Text] [Related]
4. Treatment of HTLV-III/LAV-infected patients with D-penicillamine.
Schulof RS; Scheib RG; Parenti DM; Simon GL; DiGioia RA; Paxton HM; Sztein MB; Chandra P; Courtless JW; Taguchi YT
Arzneimittelforschung; 1986 Oct; 36(10):1531-4. PubMed ID: 2949756
[TBL] [Abstract][Full Text] [Related]
5. Implications of the discovery of HTLV-III for the treatment of AIDS.
Yarchoan R; Mitsuya H; Matsushita S; Broder S
Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
[TBL] [Abstract][Full Text] [Related]
6. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
Nicholson JK; Cross GD; Callaway CS; McDougal JS
J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
[TBL] [Abstract][Full Text] [Related]
7. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS.
Chandra P; Vogel A; Gerber T
Cancer Res; 1985 Sep; 45(9 Suppl):4677s-4684s. PubMed ID: 2410112
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone.
Sarin PS; Sun D; Thornton A; Müller WE
J Natl Cancer Inst; 1987 Apr; 78(4):663-6. PubMed ID: 2435942
[TBL] [Abstract][Full Text] [Related]
10. Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV).
Balzarini J; Mitsuya H; De Clercq E; Broder S
Int J Cancer; 1986 Mar; 37(3):451-7. PubMed ID: 2419266
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by sakyomicin A of avian myeloblastosis virus reverse transcriptase and proliferation of AIDS-associated virus (HTLV-III/LAV).
Tanaka N; Okabe T; Tanaka N; Take Y; Inouye Y; Nakamura S; Nakashima H; Yamamoto N
Jpn J Cancer Res; 1986 Apr; 77(4):324-6. PubMed ID: 2422146
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.
Sarin PS; Sun DK; Thornton AH; Naylor PH; Goldstein AL
Science; 1986 May; 232(4754):1135-7. PubMed ID: 3010464
[TBL] [Abstract][Full Text] [Related]
14. Antiviral chemotherapies directed against HTLV-III/LAV.
Resnick L
Mt Sinai J Med; 1986 Dec; 53(8):648-56. PubMed ID: 3027545
[No Abstract] [Full Text] [Related]
15. Quantitative analysis of AIDS-related virus-carrying cells by plaque-forming assay using an HTLV-I-positive MT-4 cell line.
Harada S; Yamamoto N
Jpn J Cancer Res; 1985 Jun; 76(6):432-5. PubMed ID: 2991058
[TBL] [Abstract][Full Text] [Related]
16. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
[TBL] [Abstract][Full Text] [Related]
17. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
[TBL] [Abstract][Full Text] [Related]
18. Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.
Yamamoto JK; Barré-Sinoussi F; Bolton V; Pedersen NC; Gardner MB
J Interferon Res; 1986 Apr; 6(2):143-52. PubMed ID: 2425014
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.
Sandstrom EG; Kaplan JC; Byington RE; Hirsch MS
Lancet; 1985 Jun; 1(8444):1480-2. PubMed ID: 2409414
[TBL] [Abstract][Full Text] [Related]
20. Narrow host range of AIDS-related retroviruses (YU-1, 2, 3, 4) isolated from Japanese hemophiliacs: inability to infect H9, Molt-4, and MT-4 cells.
Yoshiyama H; Harada S; Kajii T; Yamamoto N
Jpn J Cancer Res; 1986 Jun; 77(6):514-6. PubMed ID: 3015850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
